SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001842952-23-000026
Filing Date
2023-02-14
Accepted
2023-02-14 17:04:29
Documents
1
Period of Report
2023-02-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_167641222454214.html 4  
1 FORM 4 wf-form4_167641222454214.xml 4 4083
  Complete submission text file 0001842952-23-000026.txt   5568
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Issuer) CIK: 0001842952 (see all company filings)

IRS No.: 863738787 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 110 MILLER AVENUE SUITE 100 ANN ARBOR MI 48104
Business Address
Minai-Azary Jennifer Lynn (Reporting) CIK: 0001844398 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40654 | Film No.: 23631281